SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ:
YI) ("111" or the "Company"), a leading integrated online and
offline healthcare platform in China, today announced that it will report its
unaudited financial results for the third quarter ended
September 30, 2019, before the open
of U.S. markets on Thursday, November 14,
2019.
111's management team will host an earnings conference call at
7:30 AM U.S. Eastern Time on
Thursday, November 14, 2019
(8:30 PM Beijing Time on the same
day).
Dial-in details for the earnings conference call are as
follows:
United
States:
|
+1-845-675-0437
|
Hong Kong:
|
+852-3018-6771 or
800-906-601
|
China:
|
4006-208-038 or
8008-190-121
|
International:
|
+65-6713-5090
|
Passcode:
|
8445615
|
Please dial in 15 minutes before the call is scheduled to begin
and provide the passcode to join the call.
A telephone replay of the call will be available after the
conclusion of the conference call until 7:59
A.M. ET on November 22,
2019:
United
States:
|
+1-855-452-5696
|
International:
|
+61-2-8199-0299
|
Passcode:
|
8445615
|
A live and archived webcast of the conference call will be
available on the Investor Relations section of 111's website
at http://ir.111.com.cn/.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
integrated online and offline healthcare platform in China. The Company provides hundreds of
millions of consumers with better access to pharmaceutical products
and medical services directly through its online retail pharmacy
and indirectly through its offline pharmacy network. 111 also
offers online medical services through its internet hospital, 1
Clinic, which provides consumers with cost-effective and convenient
online consultation and electronic prescription services. In
addition to providing direct services to consumers through its
online retail pharmacy, 111 also enables offline pharmacies to
better serve their customers. The Company's online wholesale
pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to
source a vast selection of pharmaceutical products. The Company's
New Retail platform, by integrating the front and back ends of the
pharmaceutical supply chain, has formed a smart supply chain, which
transforms the flow of pharmaceutical products to pharmacies and
modernizes how they serve their customers.
For more information on 111, please visit:
http://ir.111.com.cn/.
For more information, please contact:
111, Inc.
Ms. Monica
Mu
IR Director
ir@111.com.cn
Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com
In U.S.
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@ChristensenIR.com
View original
content:http://www.prnewswire.com/news-releases/111-to-announce-third-quarter-2019-unaudited-financial-results-on-november-14-2019-300945498.html
SOURCE 111, Inc.